{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:59:27Z","timestamp":1787068767985,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ajo.2024.03.026","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T21:15:30Z","timestamp":1712870130000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum - Age of Onset, Treatment Frequency, and Visual Outcome"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1133-8675","authenticated-orcid":false,"given":"KRISTIN","family":"RAMING","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9761-9640","authenticated-orcid":false,"given":"MAXIMILIAN","family":"PFAU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PHILIPP","family":"HERRMANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FRANK G.","family":"HOLZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3642-3502","authenticated-orcid":false,"given":"KRISTINA","family":"PFAU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajo.2024.03.026_bib0001","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0039-6257(03)00053-5","article-title":"Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update","volume":"48","author":"Hu","year":"2003","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2024.03.026_bib0002","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/21678707.2014.908702","article-title":"Pseudoxanthoma elasticum: diagnostic features, classification, and treatment options","volume":"2","author":"Uitto","year":"2014","journal-title":"Expert Opin Orphan Drugs"},{"issue":"April","key":"10.1016\/j.ajo.2024.03.026_bib0003","first-page":"1","article-title":"An update on the ocular phenotype in patients with pseudoxanthoma elasticum","volume":"4","author":"Gliem","year":"2013","journal-title":"Front Genet"},{"issue":"7","key":"10.1016\/j.ajo.2024.03.026_bib0004","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.ophtha.2009.11.008","article-title":"Centrifugal fundus abnormalities in pseudoxanthoma elasticum","volume":"117","author":"Charbel Issa","year":"2010","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2024.03.026_bib0005","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1167\/iovs.16-19388","article-title":"Frequency, phenotypic characteristics and progression of atrophy associated with a Diseased Bruch's membrane in pseudoxanthoma elasticum","volume":"57","author":"Gliem","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2024.03.026_bib0006","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/IAE.0000000000002173","article-title":"Visual acuity in pseudoxanthoma elasticum","volume":"39","author":"Risseeuw","year":"2019","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ajo.2024.03.026_bib0007","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1167\/iovs.09-3541","article-title":"Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum","volume":"50","author":"Charbel Issa","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2024.03.026_bib0008","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/IAE.0b013e3182914d2b","article-title":"Treatment of choroidal neovascularization due to angioid streaks: a comprehensive review","volume":"33","author":"Gliem","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2024.03.026_bib0009","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1477-7525-9-113","article-title":"The relative impact of vision impairment and cardiovascular disease on quality of life: the example of pseudoxanthoma elasticum","volume":"9","author":"Finger","year":"2011","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"10.1016\/j.ajo.2024.03.026_bib0010","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/IAE.0000000000001744","article-title":"Efficacy and safety of ranibizumab for the treatment of choroidal neovascularization due to uncommon cause: twelve-month results of the MINERVA study","volume":"38","author":"Lai","year":"2018","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajo.2024.03.026_bib0011","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00417-019-04551-4","article-title":"Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study","volume":"258","author":"Gliem","year":"2020","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.026_bib0012","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ajo.2011.03.022","article-title":"Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: A one-year prospective study","volume":"152","author":"Finger","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.03.026_bib0013","unstructured":"Finger RP, Charbel Issa P, Schmitz-Valckenberg S, Holz FG, Scholl HN. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum."},{"issue":"5","key":"10.1016\/j.ajo.2024.03.026_bib0014","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/IAE.0b013e3181c596b1","article-title":"Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum","volume":"30","author":"Myung","year":"2010","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.026_bib0015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ajmg.a.33329","article-title":"Proposal for updating the pseudoxanthoma elasticum classification system and a review of the clinical findings","volume":"152A","author":"Plomp","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.026_bib0016","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jamaophthalmol.2022.6396","article-title":"Diagnostic accuracy of the Amsler grid test for detecting neovascular age-related macular degeneration: a systematic review and meta-analysis","volume":"141","author":"Bjerager","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2024.03.026_bib0017","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/aos.15094","article-title":"What about the fellow eye in treatment of neovascular age-related macular degeneration? Analysis of data from the Swedish macula register","volume":"100","author":"L\u00f6vestam Adrian","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2024.03.026_bib0018","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.oret.2022.01.019","article-title":"Prophylactic ranibizumab to prevent neovascular age-related macular degeneration in vulnerable fellow eyes: a randomized clinical trial","volume":"6","author":"Chan","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"10.1016\/j.ajo.2024.03.026_bib0019","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamaophthalmol.2021.0221","article-title":"Intravitreal aflibercept injection vs sham as prophylaxis against conversion to exudative age-related macular degeneration in high-risk eyes: a randomized clinical trial","volume":"139","author":"Heier","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2024.03.026_bib0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/IAE.0000000000000745","article-title":"Intravitreal ranibizumab for choroidal neovascularization in angioid streaks: 4-year follow-up","volume":"36","author":"Tilleul","year":"2016","journal-title":"Retina"},{"issue":"1-2","key":"10.1016\/j.ajo.2024.03.026_bib0021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000477498","article-title":"Long-term follow-up of choroidal neovascularization due to angioid streaks with pro re nata intravitreal anti-VEGF treatment","volume":"238","author":"Giacomelli","year":"2017","journal-title":"Ophthalmologica"},{"issue":"3","key":"10.1016\/j.ajo.2024.03.026_bib0022","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s41433-020-0979-9","article-title":"Long-term follow-up of management of choroidal neovascularisation secondary to angioid streaks with intravitreal anti-vascular endothelial growth factor","volume":"35","author":"Ramakrishnan","year":"2021","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.ajo.2024.03.026_bib0023","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bjophthalmol-2014-305327","article-title":"Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration","volume":"99","author":"Holz","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2024.03.026_bib0024","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI86418","article-title":"VEGF regulates local inhibitory complement proteins in the eye and kidney","volume":"127","author":"Keir","year":"2017","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ajo.2024.03.026_bib0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9440(10)65138-3","article-title":"Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation","volume":"155","author":"Blaauwgeers","year":"1999","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ajo.2024.03.026_bib0026","first-page":"152","article-title":"Pigmentary retinopathy and chronic subretinal fluid associated with pseudoxanthoma elasticum and angioid streaks","volume":"17","author":"R Starr","year":"2022","journal-title":"J Ophthalmic Vis Res"},{"issue":"3","key":"10.1016\/j.ajo.2024.03.026_bib0027","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/IAE.0b013e3181f056ce","article-title":"Multimodal fundus imaging of pseudoxanthoma elasticum","volume":"31","author":"Zweifel","year":"2011","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ajo.2024.03.026_bib0028","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1001\/jamaophthalmol.2020.4335","article-title":"Mesopic and scotopic light sensitivity and its microstructural correlates in pseudoxanthoma elasticum","volume":"138","author":"Hess","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2024.03.026_bib0029","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.oret.2019.09.016","article-title":"Type 1 choroidal neovascularization is associated with reduced localized progression of atrophy in age-related macular degeneration","volume":"4","author":"Pfau","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajo.2024.03.026_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajo.2017.07.009","article-title":"Treatment-na\u00efve quiescent choroidal neovascularization in geographic atrophy secondary to nonexudative age-related macular degeneration","volume":"182","author":"Capuano","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2024.03.026_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217805","article-title":"Progression of subclinical choroidal neovascularization in age-related macular degeneration","volume":"14","author":"Heiferman","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ajo.2024.03.026_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2009.08.003","article-title":"The dynamic nature of Bruch's membrane","volume":"29","author":"Booij","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"3-4","key":"10.1016\/j.ajo.2024.03.026_bib0033","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00409836","article-title":"Bruch's membrane in pseudoxanthoma elasticum. Histochemical, ultrastructural, and x-ray microanalytical study of the membrane and angioid streak areas","volume":"203","author":"Jensen","year":"1977","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol."},{"issue":"7","key":"10.1016\/j.ajo.2024.03.026_bib0034","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ophtha.2020.01.040","article-title":"Nonexudative macular neovascularization supporting outer retina in age-related macular degeneration: a clinicopathologic correlation","volume":"127","author":"Chen","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.03.026_bib0035","doi-asserted-by":"crossref","unstructured":"Spaide, Richard & Ohno-Matsui, K. & Yannuzzi LA. Pathologic Myopia.; 2014.","DOI":"10.1007\/978-1-4614-8338-0"},{"issue":"3","key":"10.1016\/j.ajo.2024.03.026_bib0036","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ophtha.2013.10.023","article-title":"RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia","volume":"121","author":"Wolf","year":"2014","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2024.03.026_bib0037","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/jmg.2004.030171","article-title":"Pseudoxanthoma elasticum: A clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations","volume":"42","author":"Chassaing","year":"2005","journal-title":"J Med Genet"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424001375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424001375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T20:10:33Z","timestamp":1724357433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424001375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":37,"alternative-id":["S0002939424001375"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.03.026","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum - Age of Onset, Treatment Frequency, and Visual Outcome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}